Blog

Single Anastomosis Sleeve Ileal Bypass Shows Strong Results

Single anastomosis sleeve ileal bypass is a promising option for treating obesity and its related conditions.

  • Significant weight loss achieved: 63% at 6 months, 82% at 12 months, and 93% at 24 months.
  • High remission rates for conditions like diabetes (93%) and hypertension (79%).

Most complications are mild, with a mean rate of 14%. No reported deaths highlight its safety for patients.

Surgeons should consider SASI bypass as a viable choice for patients with a high BMI and multiple obesity-related comorbidities.

Journal Article by Rodrigues de Oliveira Filho J, Bregion PB (…) Griggs CL et 4 al. in Surg Endosc

© 2025. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

read the whole article in Surg Endosc

open it in PubMed

Surgeons Improve Outcomes with Data-Driven Quality Initiatives

A surgeon-specific approach significantly boosts safety and outcomes for inpatient surgeries.

  • Mortality rate fell from 0.64% to 0.17% (p = 0.003) over three years.
  • Length of stay index decreased from 0.97 to 0.92 (p = 0.03).

This initiative emphasizes tailored patient selection and standardized pathways, suggesting surgeons can enhance performance and patient care through collaborative practices.

  • Readmission rates remained stable while adopting more robotic surgeries and engaging palliative care for high-risk patients.

Journal Article by Kim MP, Mulpur S (…) Gaber AO et 3 al. in J Surg Res

Copyright © 2025 Elsevier Inc. All rights reserved.

read the whole article in J Surg Res

open it in PubMed

Elderly patients with esophageal cancer face high complication rates after surgery

Esophagectomy with colonic interposition shows a 53% complication rate, posing challenges in surgical outcomes.

  • Major complications include anastomotic leakage (22.9%) and pneumonia (19.3%).
  • Preoperative malnutrition and synchronous gastrectomy significantly increase complication risk (odds ratios 5.31 and 7.46, respectively).

Addressing these factors is vital for enhancing patient selection and improving overall survival and cancer-specific outcomes.

  • Complications also correlate with worsened survival rates (hazard ratios 2.17 and 2.52).

Journal Article by Takahashi N, Okamura A (…) Watanabe M et 6 al. in Dis Esophagus

© The Author(s) 2025. Published by Oxford University Press on behalf of the International Society for Diseases of the Esophagus. All rights reserved. For commercial re-use, please contact reprints@oup.com for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site—for further information please contact journals.permissions@oup.com.

read the whole article in Dis Esophagus

open it in PubMed

Rising obesity deaths in emergency abdominal surgeries

Obesity dramatically raises mortality risk in acute abdominal surgery patients, making targeted interventions critical.

  • Overall obesity-related mortality rose from 2.05 to 5.5 per million (1999-2020), with a notable jump after 2018.
  • Women have higher mortality rates, but men show faster increases in the obesity group.

Awareness of racial disparities is crucial, as non-Hispanic American Indians show the highest mortality rates.

  • The South saw the steepest regional increase, indicating a need for localized surgical strategies.

Journal Article by Kamran H, Bhatti MU (…) Sherafgan K et 6 al. in Am J Surg

Copyright © 2025 Elsevier Inc. All rights reserved.

read the whole article in Am J Surg

open it in PubMed

Minimally Invasive Techniques Outperform Traditional Esophagectomy

Minimally invasive and robotic-assisted approaches for esophagectomy reduce complications.

  • Reduced risk of pulmonary complications: mie (RR 0.46) and ramie (RR 0.48) outperform open and hybrid techniques.
  • Significantly lower intraoperative blood loss and shorter hospital stays for mie and ramie.

These findings support selecting minimally invasive techniques for better postoperative outcomes, without compromising cancer control.

  • Perioperative outcomes like anastomotic leak and mortality were comparable across all approaches.

Systematic Review by Aiolfi A, Cammarata F (…) Bonavina L et 2 al. in Int J Surg

Copyright © 2025 The Author(s). Published by Wolters Kluwer Health, Inc.

read the whole article in Int J Surg

open it in PubMed

Refining Hepatocellular Carcinoma Risk: Tertiary Lymphoid Structures Matter

Integrating tertiary lymphoid structures (TLS) with microvascular invasion (MVI) improves risk stratification in hepatocellular carcinoma (HCC) patients post-surgery.

  • Patients with TLS + and MVI – had the best outcomes, while TLS – and MVI + showed the worst, suggesting significant prognostic value.
  • In a multi-cohort study of 923 patients, those with TLS + had a recurrence-free survival (RFS) of 19.57 months compared to 8.53 months for TLS -.

This data can guide personalized treatment strategies, helping to identify patients who may benefit most from adjuvant therapies like hepatic arterial infusion chemotherapy.

  • No overall survival difference was found between TLS + and TLS – groups in the therapy cohort.

Multicenter Study by Ma L, Liao S (…) Xing K et 5 al. in Int J Surg

Copyright © 2025 The Author(s). Published by Wolters Kluwer Health, Inc.

read the whole article in Int J Surg

open it in PubMed

Global Cancer Outcomes Linked to Healthcare Resource Disparities

Unequal access to healthcare resources significantly affects cancer diagnosis, treatment, and survival rates.

  • A strong link exists between high universal healthcare coverage and improved cancer incidence rates (1.77) and survival (1.60).
  • Approximately 21% of cancer deaths could be prevented with better resource allocation, with survival rates aligning with advanced countries.

Targeted policies to improve healthcare resources could lead to better surgical outcomes and reduced mortality rates.

  • Areas with high healthcare expenditure also show improved cancer outcomes but less significantly than the universal health coverage index.

Journal Article by Zhu Q, Sun K (…) Zheng R et 5 al. in Int J Surg

Copyright © 2025 The Author(s). Published by Wolters Kluwer Health, Inc.

read the whole article in Int J Surg

open it in PubMed

No Drains? New Option for Rectal Cancer Surgery

Microporous polysaccharide hemospheres significantly reduce complications in rectal cancer surgery without drains.

  • Surgical complications were 12.2% in the mph group compared to 26.2% with prophylactic drains.
  • The odds of complications in the mph group were nearly half that of the no-drain group (odds ratio: 0.54).

Consider adopting mph to enhance recovery protocols and minimize postoperative risks.

  • Fewer cases of anastomotic leaks, hemorrhages, and surgical site infections were reported with mph.

Comparative Study by Blanco FJ, Castillo J (…) Ramirez JM et 17 al. in Int J Surg

Copyright © 2025 The Author(s). Published by Wolters Kluwer Health, Inc.

read the whole article in Int J Surg

open it in PubMed

Adjuvant Chemotherapy’s Benefit in Perihilar Cholangiocarcinoma

Log odds of metastatic lymph nodes is crucial for improving outcomes in patients undergoing surgery for perihilar cholangiocarcinoma.

  • Patients with log odds of metastatic lymph nodes ≥ -2.0 saw a survival advantage from adjuvant chemotherapy (31.3 months vs 20.1 months).
  • Those with log odds < -2.0 showed no survival benefit (69.2 months vs 51.0 months).

Utilizing log odds of metastatic lymph nodes can better guide decisions on adjuvant treatment, helping select patients who will benefit most.

Journal Article by Kawashima J, Akabane M (…) Pawlik TM et 15 al. in BMC Surg

Copyright © 2025 Elsevier Inc. All rights reserved.

read the whole article in BMC Surg

open it in PubMed

CRS/HIPEC Improves Survival in Low-Grade Appendiceal Carcinoma

CRS/HIPEC significantly enhances survival for select low-grade appendiceal carcinoma patients with peritoneal and parenchymal metastases.

  • Median overall survival (OS) for low-grade mucinous and non-mucinous patients after CRS/HIPEC was not reached, compared to 50 months for surgery alone and 26 months for systemic chemotherapy (p < 0.01).
  • In multivariable analysis, CRS/HIPEC reduced mortality risk for low-grade mucinous (HR 0.48) and non-mucinous (HR 0.15) cases (p < 0.01).

Consider CRS/HIPEC for suitable low-grade cases to improve patient outcomes.

Journal Article by Baron E, Wu CC, Wernberg JA and Sharma R in Eur J Surg Oncol

Copyright © 2025 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.

read the whole article in Eur J Surg Oncol

open it in PubMed